---
figid: PMC10252036__cancers-15-02886-g002
figtitle: Various mechanisms that have been reported to regulate epithelial–mesenchymal
  transition (EMT) in SACC patients
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10252036
filename: cancers-15-02886-g002.jpg
figlink: /pmc/articles/PMC10252036/figure/F2
number: F2
caption: 'Schematic representation of various mechanisms that have been reported to
  regulate epithelial–mesenchymal transition (EMT) in SACC patients. Five distinct
  regulatory mechanisms have been identified, including hypoxia, the activation of
  growth factors and developmental pathways (such as the transforming growth factor
  ß (TGF-ß) and Wnt signaling pathway), interaction between cancer-associated fibroblasts
  and adjacent tumor cells, and genomic or epigenomic alterations (such as MYB-NFIB
  fusion, p53 mutation, and microRNA (miR) expression). These factors play a significant
  role in the modulation of the epithelial–mesenchymal spectrum. VEGF: vascular endothelial
  growth factor; EGF: epidermal growth factor; FGF: fibroblast growth factor; PDGF:
  platelet-derived growth factor; HGF: hepatocyte growth factor; RTK: receptor tyrosine
  kinase; mTOR: mammalian target of rapamycin; GSK3β: glycogen synthase kinase-3 beta;
  CK1a: casein kinase 1a; APC: adenomatous polyposis coli; LEF: lymphoid enhancer-binding
  factor; TCF: T cell factors; HIF1α: hypoxia-inducible factor 1-alpha. (Figure created
  using BioRender, Toronto, ON, Canada)'
papertitle: 'Unraveling the Role of Epithelial–Mesenchymal Transition in Adenoid Cystic
  Carcinoma of the Salivary Glands: A Comprehensive Review'
reftext: Cosima C. Hoch, et al. Cancers (Basel). 2023 Jun;15(11).
year: '2023'
doi: 10.3390/cancers15112886
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: epithelial–mesenchymal transition | mesenchymal–epithelial transition |
  epithelial–mesenchymal plasticity | salivary adenoid cystic carcinoma | metastasis
  | biomarkers
automl_pathway: 0.9416196
figid_alias: PMC10252036__F2
figtype: Figure
redirect_from: /figures/PMC10252036__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10252036__cancers-15-02886-g002.html
  '@type': Dataset
  description: 'Schematic representation of various mechanisms that have been reported
    to regulate epithelial–mesenchymal transition (EMT) in SACC patients. Five distinct
    regulatory mechanisms have been identified, including hypoxia, the activation
    of growth factors and developmental pathways (such as the transforming growth
    factor ß (TGF-ß) and Wnt signaling pathway), interaction between cancer-associated
    fibroblasts and adjacent tumor cells, and genomic or epigenomic alterations (such
    as MYB-NFIB fusion, p53 mutation, and microRNA (miR) expression). These factors
    play a significant role in the modulation of the epithelial–mesenchymal spectrum.
    VEGF: vascular endothelial growth factor; EGF: epidermal growth factor; FGF: fibroblast
    growth factor; PDGF: platelet-derived growth factor; HGF: hepatocyte growth factor;
    RTK: receptor tyrosine kinase; mTOR: mammalian target of rapamycin; GSK3β: glycogen
    synthase kinase-3 beta; CK1a: casein kinase 1a; APC: adenomatous polyposis coli;
    LEF: lymphoid enhancer-binding factor; TCF: T cell factors; HIF1α: hypoxia-inducible
    factor 1-alpha. (Figure created using BioRender, Toronto, ON, Canada)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - HGF
  - IL6
  - SOS1
  - KIT
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - YAP1
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - HIF1A
  - ITK
  - SLC22A3
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CDH2
  - FN1
  - VIM
  - CDH1
  - FZR1
  - MYB
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - SNAI1
  - SNAI2
  - CTNNB1
  - CSNK1A1
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - NFIB
  - TP53
  - TP63
  - TP73
  - MIR155
  - MIR222
  - TGFB1
  - TGFB2
  - TGFB3
  - HNF4A
  - Nucleus
  - Fibronectin
  - Cancer
---
